Antibody Engineering & Therapeutics Europe
Mike Taussig will give a presentation at the Antibody Engineering & Therapeutics Europe virtual conference
Rescheduled date: August 25 - 27 2020
European Congress on Biotechnology
CPA will attend the rescheduled European Congress on Biotechnology being held in Maastricht, The Netherlands, May 9 - 12 2021.
Abcam Event: Reproducible Science Week
Mike Taussig participated in the virtual fireside chat during the Abcam Reproducible Science Week (June 1-5 2020), on the role of antibody suppliers in supporting scientific reproducibility.
Webinar on antibody validation using protein arrays
Dr Mike Taussig, CEO of CPA, gave a webinar about the validation of antibodies via protein arrays.
Autoantigenomics: holistic characterization of autoantigen repertoires
CPA contributed to a review about autoantigen profiling for Autoimmunity Reviews.